Revolutionizing Early-Stage NSCLC Treatment: Pathologists’ Key Insights into Predicting Pathologic Responses to Immunotherapies

11:30 AM - 11:35 AM ET

Melissa Johnson, MD

11:35 AM - 12:00 PM ET

Ignacio I. Wistuba, MD

View Slides

12:00 PM - 12:20 PM ET

Solange Peters, MD, PhD

View Slides

12:20 PM - 12:40 PM ET

Melissa Johnson, MD

View Slides

12:40 PM - 1:00 PM ET

Edward Garon, MD, MS

View Slides

1:00 PM - 1:10 PM ET

Melissa Johnson, MD

1:10 PM - 1:15 PM ET

Concluding Remarks